Literature DB >> 16443945

Temporal trends in incidence of primary brain tumors in the United States, 1985-1999.

Sara Hoffman1, Jennifer M Propp, Bridget J McCarthy.   

Abstract

A number of reports have indicated an increasing incidence of primary brain tumors over the past few decades. The purpose of this study was to describe incidence rate trends in a population-based series of newly diagnosed primary nonmalignant and malignant brain and other CNS tumors, contributing five additional years to previously published incidence trends. Data for the years 1985 through 1999 from six collaborating state cancer registries of the Central Brain Tumor Registry of the United States were used to determine incidence trends in the broad age groups 0-19, 20-64, and >or=65 years, overall and for selected histologies. Multiplicative Poisson regression was used to express trends as average annual percent change (AAPC). Joinpoint regression was used to identify sharp changes in incidence occurring over this period. Overall, incidence increased modestly (AAPC, 1.1; 95% CI, 0.8-1.4). When brain lymphomas were excluded, this increase remained statistically significant. A sharp change in incidence of brain lymphomas from increasing to decreasing over time was identified. Specific histologies that were increasing included anaplastic astrocytomas in individuals aged >or=65 years, microscopically confirmed gliomas in both adult age groups, and microscopically confirmed glioma, not otherwise specified (NOS), in children. Increases that were not specific to any population subgroup were seen for oligodendrogliomas, ependymomas, meningiomas, and nerve sheath tumors. Decreases were noted for astrocytoma, NOS, nonmicroscopically confirmed gliomas, and pituitary tumors. Improvements in diagnosis and classification are likely reflected in the decreasing trends in unspecified glioma subgroups and the accompanying increasing trends in more specific glioma subgroups. However, increases in meningiomas and nerve sheath tumors deserve further attention.

Entities:  

Mesh:

Year:  2006        PMID: 16443945      PMCID: PMC1871920          DOI: 10.1215/S1522851705000323

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  46 in total

1.  Is brain cancer mortality increasing in industrial countries?

Authors:  D L Davis; A Ahlbom; D Hoel; C Percy
Journal:  Am J Ind Med       Date:  1991       Impact factor: 2.214

2.  Time trends in incidence of brain and central nervous system cancers in Connecticut.

Authors:  A P Polednak
Journal:  J Natl Cancer Inst       Date:  1991-11-20       Impact factor: 13.506

3.  The status of MRI in 1986: rates of adoption in the United States and worldwide.

Authors:  E P Steinberg
Journal:  AJR Am J Roentgenol       Date:  1986-09       Impact factor: 3.959

4.  X-ray CT and magnetic resonance imagers. Diffusion patterns and policy issues.

Authors:  E P Steinberg; J E Sisk; K E Locke
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

5.  Increasing annual incidence of primary malignant brain tumors in the elderly.

Authors:  N H Greig; L G Ries; R Yancik; S I Rapoport
Journal:  J Natl Cancer Inst       Date:  1990-10-17       Impact factor: 13.506

6.  Descriptive epidemiology of vestibular schwannomas.

Authors:  Jennifer M Propp; Bridget J McCarthy; Faith G Davis; Susan Preston-Martin
Journal:  Neuro Oncol       Date:  2006-01       Impact factor: 12.300

7.  Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999.

Authors:  T B Johannesen; E Angell-Andersen; S Tretli; F Langmark; K Lote
Journal:  Neuroepidemiology       Date:  2004 May-Jun       Impact factor: 3.282

8.  Increasing incidence of primary malignant brain tumors: influence of diagnostic methods.

Authors:  M Desmeules; T Mikkelsen; Y Mao
Journal:  J Natl Cancer Inst       Date:  1992-03-18       Impact factor: 13.506

9.  Childhood cancer registry of the Province of Torino, Italy. Survival, incidence, and mortality over 20 years.

Authors:  M L Mosso; R Colombo; L Giordano; G Pastore; B Terracini; C Magnani
Journal:  Cancer       Date:  1992-03-01       Impact factor: 6.860

10.  Increasing brain cancer rates in Canada.

Authors:  Y Mao; M Desmeules; R M Semenciw; G Hill; L Gaudette; D T Wigle
Journal:  CMAJ       Date:  1991-12-15       Impact factor: 8.262

View more
  79 in total

Review 1.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

2.  Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.

Authors:  R Velasco; S Mercadal; F Graus; N Vidal; M Alañá; M I Barceló; M J Ibáñez-Juliá; S Bobillo; R Caldú Agud; E García Molina; P Martínez; P Cacabelos; A Muntañola; G García-Catalán; J M Sancho; I Camro; T Lado; M E Erro; L Gómez-Vicente; A Salar; A C Caballero; M Solé-Rodríguez; J Gállego Pérez-Larraya; N Huertas; J Estela; M Barón; N Barbero-Bordallo; M Encuentra; I Dlouhy; J Bruna
Journal:  J Neurooncol       Date:  2020-06-10       Impact factor: 4.130

Review 3.  Primary central nervous system lymphoma: implication of high-dose chemotherapy followed by auto-SCT.

Authors:  N Reddy; B N Savani
Journal:  Bone Marrow Transplant       Date:  2011-10-17       Impact factor: 5.483

Review 4.  Molecular genetics of pediatric central nervous system tumors.

Authors:  Nicole J Ullrich; Scott L Pomeroy
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

Review 5.  Functional outcome and postoperative complications after the microsurgical removal of large vestibular schwannomas via the retrosigmoid approach: a meta-analysis.

Authors:  Peng Zou; Lin Zhao; Ping Chen; Haitao Xu; Ning Liu; Peng Zhao; Ailin Lu
Journal:  Neurosurg Rev       Date:  2013-06-16       Impact factor: 3.042

6.  [Molecular diagnostic testing in gliomas].

Authors:  M Hasselblatt
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

7.  The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.

Authors:  Adelheid Wöhrer; Thomas Waldhör; Harald Heinzl; Monika Hackl; Johann Feichtinger; Ulrike Gruber-Mösenbacher; Andreas Kiefer; Hans Maier; Reinhard Motz; Angelika Reiner-Concin; Bernd Richling; Carmen Idriceanu; Michael Scarpatetti; Roland Sedivy; Hans-Christian Bankl; Wolfgang Stiglbauer; Matthias Preusser; Karl Rössler; Johannes Andreas Hainfellner
Journal:  J Neurooncol       Date:  2009-06-28       Impact factor: 4.130

8.  Cancers of the brain and CNS: global patterns and trends in incidence.

Authors:  Adalberto Miranda-Filho; Marion Piñeros; Isabelle Soerjomataram; Isabelle Deltour; Freddie Bray
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

9.  Thallium-201SPECT assessment in the detection of recurrences of treated gliomas and ependymomas.

Authors:  Ana Paula Caresia; Joan Castell-Conesa; Montserra Negre; Antoni Mestre; Gemma Cuberas; Anabel Mañes; Xavier Maldonado
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

10.  Incidence of first primary central nervous system tumors in California, 2001-2005.

Authors:  Monica Brown; Rudolph Schrot; Katrina Bauer; Deanna Letendre
Journal:  J Neurooncol       Date:  2009-04-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.